Search Results
Aug 06, 2026, 08:00 ET ONCOR REPORTS SECOND QUARTER 2026 RESULTS
(2,799)Net change in cash, cash equivalents and restricted cash
More news about: Oncor Electric Delivery Company LLC
Aug 06, 2026, 08:00 ET Edgewise Therapeutics Reports Second Quarter 2026 Financial Results
Quarter 2026 Financial ResultsCash, cash equivalents and marketable securities were approximately $460.7 million as of June 30, 2026. Our cash and cash equivalents at June 30, 2026 do not include the $1,550.0 million in upfront cash proceeds for the sale of sevasemten on July 10,
More news about: Edgewise Therapeutics
Aug 06, 2026, 08:00 ET FOX REPORTS FOURTH QUARTER FISCAL 2026 REVENUE OF $4.21 BILLION, NET INCOME OF $696 MILLION, AND ADJUSTED EBITDA OF $1.20 BILLION
Cash and cash equivalents$ 4,205
More news about: Fox Corporation
Aug 06, 2026, 08:00 ET Whitehawk Therapeutics Reports Second Quarter 2026 Financial Results and Recent Highlights
pipeline. Second Quarter 2026 Financial Results:Cash, cash equivalents and short-term investments as of June 30, 2026, were $190.0 million as compared to $145.7 million as of December 31, 2025. Cash is anticipated to fund operations into 2H 2028 based on current plans. Research
More news about: Whitehawk Therapeutics, Inc.
Aug 06, 2026, 08:00 ET Burford Reports 2Q26 and YTD26 Financial Results
commented:"Burford generated more cash this quarter than any since the first quarter of 2025, and July saw strong momentum in the portfolio."With $733 million of cash on hand, Burford is well-positioned to continue growing its industry-leading platform while strong liquidity and robust cash receipts allow us
More news about: Burford Capital Limited
Aug 06, 2026, 08:00 ET Novavax Reports Second Quarter 2026 Financial Results and Operational Highlights
earned for the Nuvaxovid U.S. BLA approval and a $27 million Takeda amendment.Cash, cash equivalents, marketable securities and restricted cash (Cash) were $724 million as of June 30, 2026, compared to $751 million as of December 31, 2025.Financial
More news about: Novavax, Inc.
Aug 06, 2026, 08:00 ET WHITE MOUNTAINS REPORTS SECOND QUARTER RESULTS
EBITDA. The items relate to (i) non-cash equity-based compensation expense, (ii) restructuring expenses and (iii) legal settlement expenses. A description of each item follows:Non-cash equity-based compensation expense - Represents non-cash expenses related to Distinguished's
More news about: White Mountains Insurance Group, Ltd.
Aug 06, 2026, 08:00 ET RiskExec Welcomes Ahsan Shah as Chief Product & Technology Officer, Leading AI and Platform Strategy
Before joining RiskExec, he served as Senior Vice President of AI & Analytics at Billtrust, where he built agentic AI systems across the order-to-cash lifecycle, along with the internal AI platforms and tooling that supported them.Shah previously held technology and product leadership roles
More news about: RiskExec, Inc.
Aug 06, 2026, 08:00 ET Bernstein Litowitz Berger & Grossmann LLP Announces Proposed Class Action Settlement on Behalf of Purchasers of iRhythm Technologies, Inc. Common Stock
Quentin Blackford (together, "Defendants") have reached a proposed settlement of the Action on behalf of the Settlement Class for $45,000,000 in cash (the "Settlement"). If approved by the Court, the Settlement will resolve all claims in the Action.In the Action, Lead Plaintiff asserts federal
More news about: Bernstein Litowitz Berger & Grossmann LLP
Aug 06, 2026, 07:55 ET KOPPERS REPORTS SECOND QUARTER 2026 RESULTS
throughput from network optimization efforts.Operating cash flow for the six months ended June 30, 2026, was a record $96.3 million compared to $27.8 million in the prior year period. The primary source of cash was net income excluding non-cash items, principally impairment, depreciation and in 2025,
More news about: KOPPERS HOLDINGS INC.
Aug 06, 2026, 07:55 ET Sempra Reports Strong Second-Quarter 2026 Results
Effect of exchange rate changes on cash, cash equivalents and restricted cash1
More news about: Sempra
Aug 06, 2026, 07:36 ET UK COMPETITION AND MARKETS AUTHORITY APPROVES PARAMOUNT SKYDANCE CORPORATION ACQUISITION OF WARNER BROS. DISCOVERY
associated with Paramount's holding company structure, including its dependence on distributions from its subsidiaries to meet tax obligations and other cash requirements; disruptions the merger may cause to Paramount's and WBD's business and commercial relationships; the negative impact that a failure to
More news about: Paramount Skydance Corporation
Aug 06, 2026, 07:30 ET Fidelity National Financial Announces Quarterly Cash Dividend of $0.52
2026 /PRNewswire/ -- Fidelity National Financial, Inc. (NYSE: FNF) ("FNF") today announced that its Board of Directors has declared a quarterly cash dividend of $0.52 per share of common stock. The dividend will be payable September 30, 2026, to stockholders of record as of September 16, 2026.
More news about: Fidelity National Financial, Inc.
Aug 06, 2026, 07:30 ET ATI Announces Second Quarter 2026 Results
costs.Adjusted Free Cash FlowManagement uses a non-GAAP measure, Adjusted free cash flow, to assess the cash flow generation of the Company's operations. Adjusted free cash flow is defined as the total cash provided by (used in) operating activities and investing
More news about: ATI
Aug 06, 2026, 07:30 ET Cars.com Reports Second Quarter 2026 Results
operating leverage against revenue growth.Cash Flow and Balance SheetNet cash provided by operating activities for the six-month period ended June 30, 2026 was $55.6 million, compared to $55.7 million in the prior year. Free cash flow for the six-month period ended June 30, 2026 totaled
More news about: Cars.com Inc.
Aug 06, 2026, 07:30 ET Nova Reports Record Second Quarter 2026 Financial Results
Changes in cash and cash equivalents and restricted cash(296,970)
More news about: Nova
Aug 06, 2026, 07:30 ET Payoneer Reports Second Quarter 2026 Financial Results
Net change in cash, cash equivalents, restricted cash and customer funds
More news about: Payoneer
Aug 06, 2026, 07:30 ET F&G Annuities & Life Declares Dividends on Common and Preferred Stock
its Board of Directors has declared a quarterly cash dividend in the amount of $0.25 per common share. The dividend will be payable on September 30, 2026, to stockholders of record as of September 16, 2026. The Board also declared a quarterly cash dividend of $0.859375 per share of F&G's 6.875%
More news about: F&G Annuities & Life, Inc.
Aug 06, 2026, 07:30 ET SUNSTONE HOTEL INVESTORS REPORTS RESULTS FOR SECOND QUARTER 2026
Balance Sheet and Liquidity UpdateAs of June 30, 2026, the Company had $203.7 million of cash and cash equivalents, including restricted cash of $109.3 million, total assets of $3.0 billion, including $2.7 billion of net investments in hotel properties and assets held
More news about: Sunstone Hotel Investors, Inc.
Aug 06, 2026, 07:30 ET Suburban Propane Partners, L.P. Announces Third Quarter Results
a rising and volatile commodity price environment, while continuing to maintain discipline over operating costs. During the quarter, we used excess cash flows and proceeds from the issuance of Common Units under our At-the-Market equity program to fund growth capital projects and reduce debt by more
More news about: Suburban Propane Partners, L.P.
Aug 06, 2026, 07:30 ET ADC Therapeutics to Host Second Quarter 2026 Financial Results Conference Call on August 13, 2026
States and foreign jurisdictions; our ability to identify and execute value-maximizing options and the cost and impact of such options; our expected cash runway into at least 2028; our ability to comply with the terms of our indebtedness; changes in our regulatory and commercial strategy; the Company's
More news about: ADC Therapeutics SA
Aug 06, 2026, 07:30 ET CME Group Declares Quarterly Dividend
www.cmegroup.com) enables clients to trade futures, options, cash and OTC markets, optimize portfolios, and analyze data – empowering market participants worldwide to efficiently manage risk and capture opportunities.
More news about: CME Group
Aug 06, 2026, 07:30 ET Nuvation Bio Reports Second Quarter 2026 Financial Results and Provides Business Update
and significant expansion of clinical program to address broad spectrum of IDH1-mutant gliomaRobust balance sheet with cash, cash equivalents, and marketable securities of $661.0 million as of June 30, 2026; additional $36.5 million in net proceeds secured in July 2026 from
More news about: Nuvation Bio, Inc.
Aug 06, 2026, 07:28 ET Charter Announces Results Of Early Tenders In Debt Exchange Offers And Amendment And Upsize of Debt Exchange Offers
1 Offer") seven series of notes issued by the CCO Issuers or the TWC Issuer, as applicable (collectively, the "Pool 1 Notes"), for a combination of cash consideration and a new series of Senior Secured Notes due 2038 (the "New 2038 Notes") to be issued by the CCO Issuers and (ii) private offer by the
More news about: Charter Communications, Inc.
Aug 06, 2026, 07:15 ET Hydreight to Participate in Canaccord Genuity's 46th Annual Growth Conference in Boston
and Drug Administration's recent advisory committee recommendations related to certain compounded peptide substances.Maintained a strong cash position to support continued organic growth, platform expansion, and strategic opportunities.Management expects discussions with investors
More news about: Hydreight Technologies Inc.